William Pierce
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 3
-
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 5
- Co-authors
- Arie S. Belldegrun (12 shared papers)Robert A. Figlin (13 shared papers)Tomasz M. Beer (1 shared paper)W. David Henner (1 shared paper)B A Lowe (1 shared paper)Jean B. deKernion (8 shared papers)Nancy P. Moldawer (3 shared papers)Faye A. Eggerding (2 shared papers)
- Journals
- The Journal of Urology (3 papers)Journal of Immunotherapy (3 papers)Cancer (1 paper)Urology (1 paper)Urologic Clinics of North America (1 paper)
- Partner nations
- United StatesIsraelAustria
In The Last Decade
William Pierce
16 papers receiving 519 citations
Peers
Comparison fields: 5 of 49
- Oncology 301
- Pulmonary and Respiratory Medicine 295
- Immunology 149
- Cancer Research 82
- Hematology 45
Countries citing papers authored by William Pierce
This map shows the geographic impact of William Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Pierce more than expected).
Fields of papers citing papers by William Pierce
This network shows the impact of papers produced by William Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Pierce. The network helps show where William Pierce may publish in the future.
Co-authors
The 25 scholars most cited alongside William Pierce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 162 | |
| 2 | 1997 | 126 | |
| 3 | 1993 | 51 | |
| 4 | 1986 | 38 | |
| 5 | 1995 | 31 | |
| 6 | Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma. | 1995 | 27 |
| 7 | 1993 | 25 | |
| 8 | 1996 | 21 | |
| 9 | Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma. | 1993 | 15 |
| 10 | 1994 | 14 | |
| 11 | 1994 | 12 | |
| 12 | 1993 | 11 | |
| 13 | 1997 | 6 | |
| 14 | 1983 | 6 | |
| 15 | 1997 | 5 | |
| 16 | 1993 | 1 | |
| 17 | 1993 | 0 |
About William Pierce
William Pierce is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, having authored 17 papers that have together received 551 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (5 papers), Renal cell carcinoma treatment (5 papers), Immune Cell Function and Interaction (5 papers), Bladder and Urothelial Cancer Treatments (3 papers), CAR-T cell therapy research (3 papers), Virus-based gene therapy research (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). The work is most often cited by research in Oncology (301 citations), Pulmonary and Respiratory Medicine (295 citations), Immunology (149 citations), Cancer Research (82 citations) and Hematology (45 citations). William Pierce has collaborated with scholars based in United States, Israel and Austria. Frequent co-authors include Arie S. Belldegrun, Robert A. Figlin, Tomasz M. Beer, W. David Henner, B A Lowe, Jean B. deKernion, Nancy P. Moldawer, Faye A. Eggerding, Barbara J. Gitlitz and C L Tso. Their work appears in journals such as The Journal of Urology, Journal of Immunotherapy, Cancer, Urology and Urologic Clinics of North America.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.